Diabetic Retinopathy Market share to reach USD 11.1 billion by 2023 - PowerPoint PPT Presentation

About This Presentation
Title:

Diabetic Retinopathy Market share to reach USD 11.1 billion by 2023

Description:

Get more information @ Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others. – PowerPoint PPT presentation

Number of Views:54

less

Transcript and Presenter's Notes

Title: Diabetic Retinopathy Market share to reach USD 11.1 billion by 2023


1
Diabetic Retinopathy Market forecast to reach USD
11.1 billion by 2023 Fractovia.org
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights of Diabetic Retinopathy Market
  • Growing old age population, increasing occurrence
    of diabetes, fast rise in cases of blindness and
    rising consciousness about early identification
    of diabetic retinopathy are the few factors
    driving the industry expansion.
  • Diabetic retinopathy is an eye disorder that
    causes damage to the retina blood vessels. It is
    a common diabetic condition affecting eyes.
    Persons suffering from diabetes are at greater
    risk of developing diabetic retinopathy.
  • The condition is mainly caused by high levels of
    glucose in blood producing changes in eye blood
    vessels. Retinopathy treatment depends upon
    ailment phase and is aimed at blocking its
    growth. Corticosteroids injections, vitrectomy
    and laser surgery are few of the available
    ailment treatments.
  • Screening of retina and line of treatment depends
    upon the seriousness of the situation ensuring
    delivery of proper treatment. Diabetes is
    considered to be main cause of blindness in
    people.

3
Continued
  • To avoid blindness, people are demanding methods
    for early identification of ailment, fuelling
    diabetic retinopathy market trends. Also, old age
    population is more prone for contracting the
    ailment and hence promotes the industry growth.
  • Further, technological breakthroughs in retinal
    screening methods and equipments like utilization
    of slit lamps and launching of new products like
    Gly-230 Optima are the factors predicted to
    drive the industry expansion. Growing occurrence
    of diabetes predicted to affect more than 4.6 of
    world population will also enhance the industry
    growth.
  • Different types of diabetic retinopathy are
    non-proliferative and proliferative.
    Non-proliferative retinopathy led the industry by
    contributing more than 4.6 billion in 2015.
    Growing diabetes occurrence, non-compliant
    retinal screening of patients and lack of right
    time diagnosis are factors predicted to fuel the
    increase in the industry share of
    non-proliferative retinopathy.

4
U.S. Diabetic Retinopathy Market size, by
management, 2012 - 2023 (USD Million)

5

Browse Full Market Research Report Diabetic
Retinopathy Market _at_ http//bit.ly/2j826wi
Request for a Sample of this Research report
_at_ https//www.fractovia.org/request-sample/136
6
Stay In Touch Website https//www.fractovia.org
Social Media
Write a Comment
User Comments (0)
About PowerShow.com